SCHEMBL20119191

SCHEMBL20119191

Nc1cccc(C2=NNNN2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 4/20 0.47
▸ MAOA P21397 1/20 0.45
▸ AURKA O14965 1/20 0.44
▸ METAP2 P50579 1/20 0.42
▸ ENPP2 Q13822 1/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ PSIP1 O75475 1/20 0.42
▸ AXL P30530 1/20 0.42
▸ MKNK1 Q9BUB5 1/20 0.42
▸ MKNK2 Q9HBH9 1/20 0.42
▸ RECQL P46063 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PDPK1 O15530 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25993393 0.78 IP6K1 (0.43) MAP4K4MEN1LMNAMAPTKMT2A
SCHEMBL18455367 0.78 NISCH (0.49) METAP2MEN1KMT2ATSHRALDH1A1
SCHEMBL19403602 0.76 ALDH1A1 (0.42) METAP2MEN1LMNAMAPTKMT2A
SCHEMBL13978012 0.76 MAP4K4 (0.53) MAP4K4MAOAAURKAMETAP2ENPP2
SCHEMBL30500254 0.70 MAOA (0.83) MAP4K4MAOAMEN1LMNAMAPT
SCHEMBL29403794 0.70 MAOA (0.83) MAP4K4MAOAMEN1LMNAMAPT
SCHEMBL251095 0.70 MAOA (0.83) MAP4K4MAOAMEN1LMNAMAPT
SCHEMBL3375366 0.68 MAP4K4 (0.44) MAP4K4MAOAAURKAMETAP2ENPP2
Water SCHEMBL2444002 0.67 MAOA (0.79) MAP4K4MAOAMEN1LMNAMAPT
Methane SCHEMBL21853746 0.67 MAOA (0.79) MAP4K4MAOAMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081285-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-05-03 — — WO disclosed
Send feedback